Chinese vaccines set to swarm developing world


Global recognition: Two Chinese vaccines are being used by many countries now – CoronaVac (left) and the WHO-listed Sinopharm vaccine (right).

With the world facing acute shortage in Covid-19 vaccines, WHO’s nod for global use of China’s Sinopharm vaccine provides a huge relief.

IN recent weeks, there has been an incessant flow of exciting news on Chinese vaccines that carries wide-ranging implications for China as well as vaccine-deprived developing countries.

On May 7, the World Health Organisation announced its approval for emergency use a Covid-19 vaccine from China’s government-owned drugmaker Sinopharm, greenlighting it to be rolled out globally.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Covid-19 vaccines , WHO , China , Sinopharm vaccine ,

Next In Columnists

Always the bridesmaid no more – Arsenal’s title is there for the taking
Thoughts on adopting Tokyo’s model in Penang
Malaysia–China Cooperation under GSI: Opportunities and Projections to 2030
Sexual and reproductive aftermath of mumps
Heed the lessons of war
Rain Rave’s success music to the ears
An elegantly delivered message
For the women caring for families, driving the nation
Asia’s clinical trials boom must deliver access, not just data
Chinese seeking the ideal Malay leader

Others Also Read